ASX-LISTED hospital healthcare group Ramsay Health Care has announced a downturn in its FY18 guidance.
Given the performance of its UK hospitals in the current challenging environment, and following a review of the carrying value of its assets, Ramsay said it would recognise a charge of 70 million (AU$125 million)net of tax based on an "onerous lease provision" and certain UK site write-downs.
The company said it has also experienced weaker growth rates in procedural work and inpatient admissions in its Australian operations in recent months and delays in the rollout of the Ramsay Pharmacy franchise network.
With "disappointing May results and with no material improvement anticipated for June, Ramsay advises that its FY18 Core EPS growth is now expected to be approximately 7% compared to the guidance of 8% to 10% previously provided," the statement revealed.
Commenting on the trading update, Ramsay md Craig McNally said, "Ramsay expects operating conditions in both the UK and Australia to remain challenging.
"Given the current climate around private health insurance and affordability, we expect this trend will continue into FY19.
"In the current climate the Company is focused on resetting and strengthening its business for the longer term."
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jun 18